M30-M36
Systemic connective tissue disorders
- M30.0Polyarteritis nodosa
- M30.1Polyarteritis with lung involvement [Churg-Strauss]
- M30.2Juvenile polyarteritis
- M30.3Mucocutaneouslymph node syndrome [Kawasaki]
- M30.8Other conditions related to polyarteritis nodosa
- M31.0Hypersensitivity angiitis
- M31.1Thrombotic microangiopathy
- M31.2Lethal midline granuloma
- M31.3Wegener's granulomatosis
- M31.4Aortic arch syndrome [Takayasu]
- M31.5Giant cell arteritis with polymyalgia rheumatica
- M31.6Other giant cell arteritis
- M31.7Microscopic polyangiitis
- M31.8Other specified necrotizing vasculopathies
- M31.9Necrotizing vasculopathy, unspecified
- M32.0Drug-induced systemic lupus erythematosus
- M32.1Systemic lupus erythematosus with organ or system involvement
- M32.8Other forms of systemic lupus erythematosus
- M32.9Systemic lupus erythematosus, unspecified
- M33.0Juvenile dermatomyositis
- M33.1Other dermatomyositis
- M33.2Polymyositis
- M33.9Dermatopolymyositis, unspecified
- M34.0Progressive systemic sclerosis
- M34.1CR(E)ST syndrome
- M34.2Systemic sclerosis induced by drugs and chemicals
- M34.8Other forms of systemic sclerosis
- M34.9Systemic sclerosis, unspecified
- M35.0Sicca syndrome [Sjogren]
- M35.1Other overlap syndromes
- M35.2Behcet's disease
- M35.3Polymyalgia rheumatica
- M35.4Diffuse (eosinophilic) fasciitis
- M35.5Multifocal fibrosclerosis
- M35.6Relapsing panniculitis [Weber-Christian]
- M35.7Hypermobility syndrome
- M35.8Other specified systemic involvement of connective tissue
- M35.9Systemic involvement of connective tissue, unspecified
- M36.0Dermato(poly)myositis in neoplastic disease (C00-D48+)
- M36.1Arthropathy in neoplastic disease (C00-D48+)
- M36.2Haemophilic arthropathy (D66-D68+)
- M36.3Arthropathy in other blood disorders (D50-D76+)
- M36.4Arthropathy in hypersensitivity reactions classified elsewhere
- M36.8Systemic disorders of connective tissue in other diseases classified elsewhere